Spotlight on olfactory dysfunction in Parkinson's disease

References

• Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012;8(6):329–339.
   PubMed Web of Science ®Google Scholar
• Chu S, Downes JJ. Odour-evoked autobiographical memories: psychological investigations of proustian phenomena. Chem Senses. 2000;25(1):111–116.
   PubMed Web of Science ®Google Scholar
• Wilson RI, Mainen ZF. Early events in olfactory processing. Annu Rev Neurosci. 2006;29:163–201.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. Olfactory system: functional organization and involvement in neurodegenerative disease. Neurology. 2010;75(12):1104–1109.
   PubMed Web of Science ®Google Scholar
• Duda JE. Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci. 2010;289(1–2):49–54.
   PubMed Web of Science ®Google Scholar
• Chen WR, Shepherd GM. The olfactory glomerulus: a cortical module with specific functions. J Neurocytol. 2005;34(3–5):353–360.
   PubMedGoogle Scholar
• Gómez C, Briñón JG, Barbado MV, Weruaga E, Valero J, Alonso JR. Heterogeneous targeting of centrifugal inputs to the glomerular layer of the main olfactory bulb. J Chem Neuroanat. 2005;29(4):238–254.
   PubMed Web of Science ®Google Scholar
• Brunjes PC, Illig KR, Meyer EA. A field guide to the anterior olfactory nucleus (cortex). Brain Res Brain Res Rev. 2005;50(2):305–335.
   PubMedGoogle Scholar
• Schiffman SS, Graham BG. Taste and smell perception affect appetite and immunity in the elderly. Eur J Clin Nutr. 2000;54(Suppl 3): S54–S63.
   PubMed Web of Science ®Google Scholar
• Oliveira-Pinto AV, Santos RM, Coutinho RA, et al. Sexual dimorphism in the human olfactory bulb: females have more neurons and glial cells than males. PLoS One. 2014;9(11):e111733.
   PubMed Web of Science ®Google Scholar
• Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226(4681):1441–1443.
   PubMed Web of Science ®Google Scholar
• Doty RL, Kamath V. The influences of age on olfaction: a review. Front Psychol. 2014;5:20.
   PubMed Web of Science ®Google Scholar
• Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288(18):2307–2312.
   PubMed Web of Science ®Google Scholar
• Moccia M, Picillo M, Erro R, et al. How does smoking affect olfaction in Parkinson’s disease? J Neurol Sci. 2014;340(1–2):215–217.
   PubMed Web of Science ®Google Scholar
• Calderón-Garcidueñas L, Franco-Lira M, Henríquez-Roldán C, et al. Urban air pollution: influences on olfactory function and pathology in exposed children and young adults. Exp Toxicol Pathol. 2010;62(1):91–102.
   PubMedGoogle Scholar
• Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839–840.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A. 1998; 95(11):6469–6473.
   PubMed Web of Science ®Google Scholar
• Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 2006;21(12):2062–2067.
   PubMed Web of Science ®Google Scholar
• Beach TG, White CL 3rd, Hladik CL, et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. 2009;117(2):169–174.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197–211.
   PubMed Web of Science ®Google Scholar
• Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318(1):121–134.
   PubMed Web of Science ®Google Scholar
• Halliday GM, McCann H. The progression of pathology in Parkinson’s disease. Ann N Y Acad Sci. 2010;1184:188–195.
   PubMed Web of Science ®Google Scholar
• Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol. 2008;63(2):167–173.
   PubMed Web of Science ®Google Scholar
• Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord. 2007;22(6):839–842.
   PubMed Web of Science ®Google Scholar
• Haehner A, Hummel T, Reichmann H. Olfactory dysfunction as a diagnostic marker for Parkinson’s disease. Expert Rev Neurother. 2009;9(12):1773–1779.
   PubMed Web of Science ®Google Scholar
• Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol. 2004;56(2):173–181.
   PubMed Web of Science ®Google Scholar
• Ponsen MM, Stoffers D, Twisk JW, Wolters ECh, Berendse HW. Hyposmia and executive dysfunction as predictors of future Parkinson’s disease: a prospective study. Mov Disord. 2009;24(7):1060–1065.
   PubMed Web of Science ®Google Scholar
• Sengoku R, Saito Y, Ikemura M, et al. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. 2008;67(11):1072–1083.
   Google Scholar
• Harding AJ, Stimson E, Henderson JM, Halliday GM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain. 2002;125(Pt 11):2431–2445.
   PubMedGoogle Scholar
• Altinayar S, Oner S, Can S, Kizilay A, Kamisli S, Sarac K. Olfactory disfunction and its relation olfactory bulb volume in Parkinson’s disease. Eur Rev Med Pharmacol Sci. 2014;18(23):3659–3664.
   PubMed Web of Science ®Google Scholar
• Hakyemez HA, Veyseller B, Ozer F, et al. Relationship of olfactory function with olfactory bulbus volume, disease duration and Unified Parkinson’s disease rating scale scores in patients with early stage of idiopathic Parkinson’s disease. J Clin Neurosci. 2013;20(10):1469–1470.
   PubMed Web of Science ®Google Scholar
• Ansari KA, Johnson A. Olfactory function in patients with Parkinson’s disease. J Chronic Dis. 1975;28(9):493–497.
   PubMedGoogle Scholar
• Xiao Q, Chen S, Le W. Hyposmia: a possible biomarker of Parkinson’s disease. Neurosci Bull. 2014;30(1):134–140.
   PubMed Web of Science ®Google Scholar
• Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand. 1995;91(4):247–250.
   PubMed Web of Science ®Google Scholar
• Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY. Olfactory dysfunction in Alzheimer’s disease. Neuropsychiatr Dis Treat. 2016;12:869–875.
   PubMed Web of Science ®Google Scholar
• Moscovich M, Munhoz RP, Teive HA, et al. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012;83(10):970–974.
   PubMed Web of Science ®Google Scholar
• Driver-Dunckley E, Adler CH, Hentz JG, et al; Arizona Parkinson Disease Consortium. Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(11):1260–1262.
   PubMed Web of Science ®Google Scholar
• Hawkes C. Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol. 2006;63:133–151.
   PubMedGoogle Scholar
• Katzenschlager R, Lees AJ. Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol. 2004;17(4):417–423.
   PubMed Web of Science ®Google Scholar
• Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord. 2003;18(4):364–372.
   PubMed Web of Science ®Google Scholar
• Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38(8):1237–1244.
   PubMed Web of Science ®Google Scholar
• Doty RL. Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis. 2012;46(3):527–552.
   PubMed Web of Science ®Google Scholar
• Potagas C, Dellatolas G, Ziegler M, et al. Clinical assessment of olfactory dysfunction in Parkinson’s disease. Mov Disord. 1998;13(3):394–399.
   PubMed Web of Science ®Google Scholar
• Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32(3):489–502.
   PubMed Web of Science ®Google Scholar
• Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94(2 Pt 1):176–178.
   PubMed Web of Science ®Google Scholar
• Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. ‘Sniffin’ sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22(1):39–52.
   PubMed Web of Science ®Google Scholar
• Lawton M, Hu MT, Baig F, et al. Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin’ Sticks test in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2016;33:96–101.
   PubMed Web of Science ®Google Scholar
• Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson’s disease: development of optimal discrimination criteria. Neurodegeneration. 1995;4(1):93–97.
   PubMedGoogle Scholar
• Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1992;55(2):138–142.
   PubMed Web of Science ®Google Scholar
• Tissingh G, Berendse HW, Bergmans P, et al. Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord. 2001;16(1):41–46.
   PubMed Web of Science ®Google Scholar
• Boesveldt S, Verbaan D, Knol DL, et al. A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Mov Disord. 2008;23(14):1984–1990.
   PubMed Web of Science ®Google Scholar
• Boesveldt S, de Muinck Keizer RJ, Knol DL, Wolters ECh, Berendse HW. Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson’s disease. Mov Disord. 2009;24(1):85–90.
   PubMed Web of Science ®Google Scholar
• Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62(5):436–446.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Violante M, Lees AJ, Cervantes-Arriaga A, Corona T, Silveira-Moriyama L. Use of smell test identification in Parkinson’s disease in Mexico: a matched case-control study. Mov Disord. 2011;26(1):173–176.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Violante M, Gonzalez-Latapi P, Camacho-Ordoñez A, Martínez-Ramírez D, Morales-Briceño H, Cervantes-Arriaga A. Comparing the accuracy of different smell identification tests in Parkinson’s disease: relevance of cultural aspects. Clin Neurol Neurosurg. 2014;123:9–14.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Miyamoto M, Iwanami M, Suzuki K, Inoue Y, Hirata K. Odor identification test as an indicator of idiopathic REM sleep behavior disorder. Mov Disord. 2009;24(2):268–273.
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, et al. The use of smell identification tests in the diagnosis of Parkinson’s disease in Brazil. Mov Disord. 2008;23(16):2328–2334.
   PubMed Web of Science ®Google Scholar
• Santin R, Fonseca VF, Bleil CB, Rieder CR, Hilbig A. Olfactory function and Parkinson’s disease in Southern Brazil. Arq Neuropsiquiatr. 2010;68(2):252–257.
   PubMed Web of Science ®Google Scholar
• Picillo M, Pellecchia MT, Erro R, et al. The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson’s disease in Italy. Neurol Sci. 2014;35(3):379–383.
   PubMed Web of Science ®Google Scholar
• Iijima M, Kobayakawa T, Saito S, et al. Differences in odor identification among clinical subtypes of Parkinson’s disease. Eur J Neurol. 2011;18(3):425–429.
   PubMed Web of Science ®Google Scholar
• Abbott RD, Ross GW, White LR, et al. Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study. J Neurol. 2003;250(Suppl 3): III30–III39.
   PubMedGoogle Scholar
• Ponsen MM, Stoffers D, Wolters ECh, Booij J, Berendse HW. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2010;81(4):396–399.
   PubMed Web of Science ®Google Scholar
• Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry. 1991;148(3):357–360.
   PubMed Web of Science ®Google Scholar
• Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol. 1998;55(1):84–90.
   PubMedGoogle Scholar
• Haugen J, Müller ML, Kotagal V, et al. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation. J Neural Transm (Vienna). 2016;123(4):421–424.
   PubMed Web of Science ®Google Scholar
• Siderowf A, Newberg A, Chou KL, et al. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology. 2005;64(10):1716–1720.
   PubMed Web of Science ®Google Scholar
• Borghammer P, Knudsen K, Østergaard K, et al. Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders. Int J Clin Pract. 2014;68(11):1345–1351.
   PubMed Web of Science ®Google Scholar
• Georgiopoulos C, Davidsson A, Engström M, Larsson EM, Zachrisson H, Dizdar N. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes. J Neurol. 2015;262(9):2154–2163.
   PubMed Web of Science ®Google Scholar
• López-Hernández N, García-Escrivá A, Shalabi Benavent M. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson’s disease. Neurología. 2015;30(8):496–501.
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Nakamura T, Okada A, et al. Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(5):520–524.
   PubMed Web of Science ®Google Scholar
• Navarro-Otano J, Gaig C, Muxi A, et al. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(2):192–197.
   PubMed Web of Science ®Google Scholar
• Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. PREDICT-PD: identifying risk of Parkinson’s disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry. 2014;85(1):31–37.
   PubMed Web of Science ®Google Scholar
• Noyce AJ, R’Bibo L, Peress L, et al. PREDICT-PD: an online approach to prospectively identify risk indicators of Parkinson’s disease. Mov Disord. 2017;32(2):219–226.
   PubMed Web of Science ®Google Scholar
• Siderowf A, Jennings D, Eberly S, et al. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord. 2012;27(3):406–412.
   PubMed Web of Science ®Google Scholar
• Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 2011;95(4):629–635.
   PubMed Web of Science ®Google Scholar
• Berg D, Godau J, Seppi K, et al. The PRIPS study: screening battery for subjects at risk for Parkinson’s disease. Eur J Neurol. 2013;20(1):102–108.
   PubMed Web of Science ®Google Scholar
• Berg D. Is pre-motor diagnosis possible? The European experience. Parkinsonism Relat Disord. 2012;18(Suppl 1):S195–S198.
   PubMedGoogle Scholar
• Gaenslen A, Wurster I, Brockmann K, et al. Prodromal features for Parkinson’s disease – baseline data from the TREND study. Eur J Neurol. 2014;21(5):766–772.
   PubMed Web of Science ®Google Scholar
• Liepelt-Scarfone I, Gauss K, Maetzler W, et al. Evaluation of progression markers in the premotor phase of Parkinson’s disease: the progression markers in the premotor phase study. Neuroepidemiology. 2013;41(3–4):174–182.
   PubMed Web of Science ®Google Scholar
• Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30(12):1600–1611.
   PubMed Web of Science ®Google Scholar
• Fullard ME, Tran B, Xie SX, et al. Olfactory impairment predicts cognitive decline in early Parkinson’s disease. Parkinsonism Relat Disord. 2016;25:45–51.
   PubMed Web of Science ®Google Scholar
• Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson’s disease: a 3 year longitudinal study. Brain. 2012;135(Pt 1):161–169.
   PubMedGoogle Scholar
• Kang SH, Lee HM, Seo WK, Kim JH, Koh SB. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease. J Neurol Sci. 2016;368:374–378.
   PubMed Web of Science ®Google Scholar
• Johansen KK, Warø BJ, Aasly JO. Olfactory dysfunction in sporadic Parkinson’s Disease and LRRK2 carriers. Acta Neurol Scand. 2014;129(5):300–306.
   PubMed Web of Science ®Google Scholar
• Saunders-Pullman R, Stanley K, Wang C, et al. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology. 2011;77(4):319–324.
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Guedes LC, Kingsbury A, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology. 2008;71(13):1021–1026.
   PubMed Web of Science ®Google Scholar
• Cao M, Gu ZQ, Li Y, et al. Olfactory dysfunction in Parkinson’s disease patients with the LRRK2 G2385R variant. Neurosci Bull. 2016;32(6):572–576.
   PubMed Web of Science ®Google Scholar
• Iranzo A, Serradell M, Vilaseca I, et al. Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord. 2013;19(6):600–604.
   PubMed Web of Science ®Google Scholar
• Cavaco S, Gonçalves A, Mendes A, et al. Abnormal Olfaction in Parkinson’s disease is related to faster disease progression. Behav Neurol. 2015;2015:976589.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601.
   PubMed Web of Science ®Google Scholar